4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 525.00
0.00 (0.00%)
Jul 24, 2026, 3:53 PM GMT
4basebio Market Cap
4basebio has a market cap or net worth of 81.58 million as of July 24, 2026. Its market cap has decreased by -45.38% in one year.
Market Cap
81.58M
Enterprise Value
80.26M
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
525.00
ChartMarket Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 81.58M, an increase of 96.23%. That is a compound annual growth rate of 13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 81.58M | -14.30% |
| Dec 31, 2025 | 95.19M | -38.57% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 97.55M |
| Faron Pharmaceuticals Oy | 90.86M |
| Bioventix | 79.68M |
| Ondine Biomedical | 71.44M |
| hVIVO | 51.53M |
| Hemogenyx Pharmaceuticals | 49.44M |
| Poolbeg Pharma | 46.95M |
| Sareum Holdings | 30.48M |